PRKDC and breast carcinoma: In relation to treatment, the expression of DNA-PKcs has been reported to drive resistance to chemotherapy and radiotherapy in preclinical models19,57, whereas inhibition of DNA-PKcs has been shown to sensitize breast cancer cells to these treatment modalities22,24.